Virtus LifeSci Biotech Clinical Trials ETF
12 hedge funds and large institutions have $3.71M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2016 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.
Holders
12
Holders Change
-5
Holders Change %
-29.41%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
3
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
LPL Financial
San Diego,
California
|
$940K |
| 2 |
2
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$37K |
| 3 |
MFS
3
MSI Financial Services
Springfield,
Massachusetts
|
$7K |
